Tumor Ablation Market Share, Top Key players Analysis, Future Business Insights and Statistics Analysis Report Forecasts 2022-2030
Market Analysis
The global Tumor
Ablation Market Share is expected to cross USD 2,459.74 million by 2030 at
a CAGR of 11.81% during the forecast period 2022-2030. Tumor ablation is a
technique that is minimally invasive and commonly used for treating tumors in
the lung, bone, kidney and liver. During this process, thermal energy is
utilized to cool or heat tissues to cytotoxic levels. Under its classification,
there are various modalities used worldwide: irreversible electroporation,
cryoablation, high-intensity focused ultrasound, laser, microwave and
radiofrequency. Every technique though similar in purpose possess optimal and
specific indications. Tumor ablation is a vital choice for those who have
failed radiotherapy or chemotherapy or is not a candidate for surgery. It is
also considered as the potential first-line treatment especially in patients
with benign tumors in the liver or small hepatocellular carcinomas. This is a
convenient and excellent treatment choice over the other conventional surgical
methods.
Key Players
Leading Tumor Ablation Market Players Profile include
Covidien PL, Misonix Inc., Galil Medical, Inc, Biotronik,
Boston Scientific Corporation, Neuwave Medical, Inc., Healthtronics Inc., AngioDynamics
Inc., EDAP TMS, Medtronic Plc., and SonaCare Medical.
Market Segmentation
Market Research Future report offers a comprehensive
segmental analysis of the Tumor
Ablation Market Trends on the basis of technology, treatment,
application and end-user.
·
Based on technology, it is segmented into
cryoablation, irreversible electroporation, microwave, radiofrequency and
others. Of these, radiofrequency will dominate the tumor ablation market during
the forecast period. Prominent use of this technology to remove solid tumor and
its specificity has resulted to its growth. Also, this method’s efficiency is
expected to spur the segment growth. This will be followed by microwave
ablation technology that is projected to have a remunerative growth due to the
advantages provided by this technology namely optimal heating of cystic mass,
reduced procedural pain, lesser time, constancy in high temperature and bigger
tumor ablation volume.
·
Based on treatment, the tumor ablation
market is segmented into laparoscopic, percutaneous and surgical. Of these,
surgical will dominate the market during the forecast period owing to rising
prevalence of breast and liver cancer that needs open surgical techniques. This
will be followed by the percutaneous ablation that is projected to grow at the
fastest pace.
·
Based on application, it is segmented
into prostate cancer, bone cancer, breast cancer, lung cancer, liver cancer and
others. Of these, liver cancer will have the largest share in the market owing
to rising cases of both bile duct as well as primary liver cancers. Of these,
lung cancer will lead the market during the forecast period owing to rising
cases of the disease.
·
Based on end-user, the tumor ablation
market is segmented into research institute, surgical and ablation centers and
hospitals. Of these, hospitals will dominate the market due to increasing
practices to visit the hospital for well-being along with the availability of
various facilities in hospitals.
Regional Analysis
By region, the Tumor
Ablation Market covers growth opportunities and latest trends across
Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas
will remain head and shoulders over other regions in the market. The growth can
be attributed to factors such as increasing incidences of cancer amid rising
elderly population, use of advanced healthcare facilities, favorable
reimbursement policies, and increasing awareness regarding cancer detection as
well as treatment. The tumor ablation market in Europe will grab the second position
owing to rising prevalence of cancer coupled with increasing healthcare
expenditure. The tumor ablation market in the APAC region will grow at the
fastest pace due to high demand for advanced healthcare technologies,
constantly growing investment in healthcare and rising geriatric population. On
the other hand, the tumor ablation market in the Middle East and Africa will
have a minimal share owing to poor medical facilities, dearth of technical
knowledge and underdeveloped healthcare sector.
March 2019- CLS (Clinical Laserthermia Systems AB) stated
that both clinical studies as well as outcomes of the imILT cancer
immunotherapy that is heat induced for tumors will be highlighted at ECIO
(European Conference on Interventional Oncology) at Netherlands on April 8-11,
2019. CLS will also take part on a hands-on, educational workshop for “tumor
ablation” highlighting its TRANSBERG thermal therapy system for high-precision,
image-guided laser ablation.
·
https://www.fdboo.com/read-blog/20057
About US:
Market Research
Future (MRFR) enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment